Neurohormonal blockade in HFrEF, we use

ARNI: Sacubitril/Valsartan, which enhances natriuretic peptides and blocks angiotensin II effects, reducing blood pressure and fluid overload.
ACE Inhibitors: Lisinopril, Enalapril, Ramipril, which prevent the formation of angiotensin II, leading to vasodilation and reduced cardiac workload.
ARBs: Losartan, Valsartan, Candesartan, which block angiotensin II receptors, decreasing vasoconstriction and sodium retention.
Beta-Blockers: Carvedilol, Bisoprolol, Metoprolol Succinate, which slow heart rate and reduce myocardial oxygen demand.
MRAs: Spironolactone, Eplerenone, which counteract aldosterone, reducing fluid retention and cardiac remodeling.
SGLT2 Inhibitors: Dapagliflozin, Empagliflozin, Canagliflozin, which cause glucose excretion and have beneficial effects on cardiac function and hospitalization rates.